Table 4:
Performance of the composite and 4D-CT MGD scores for predicting multigland disease
| No. of Patients | Sensitivity | Specificity | Positive Predictive Value | |
|---|---|---|---|---|
| Composite MGD score | ||||
| ≥1 | 28 | 100% | 5% | 41% |
| ≥2 | 26 | 93% | 16% | 42% |
| ≥3 | 24 | 86% | 51% | 53% |
| ≥4 | 22 | 79% | 72% | 65% |
| ≥5 | 13 | 46% | 86% | 68% |
| 6 | 6 | 21% | 100% | 100% |
| 4D-CT MGD score | ||||
| ≥0 | 28 | 100% | 0% | 39% |
| ≥1 | 28 | 100% | 26% | 47% |
| ≥2 | 23 | 82% | 60% | 58% |
| ≥3 | 21 | 75% | 74% | 66% |
| 4 | 9 | 32% | 88% | 64% |